Document
PGR2021-00003, No. 2006 Exhibit - Supplementary Appendix to Strosberg J, El Haddad G, Wolin E, et al ¿¿¿Phase 3 trial of 177Lu Dotatate for midgut neuroendocrine tumors,¿¿¿ New England J M...
Cite Document
PGR2021-00003, No. 2006 Exhibit - Supplementary Appendix to Strosberg J, El Haddad G, Wolin E, et al ¿¿¿Phase 3 trial of 177Lu Dotatate for midgut neuroendocrine tumors,¿¿¿ New England J Med 201737612
+ More Snippets
Document
PGR2021-00003, No. 2001 Exhibit - Price et al, ¿¿¿Role of Supplementary Material in Biomedical Journal Articles Surveys of Authors, Reviewers and Readers,¿¿¿ BMJ Open 2018 20188e021753 d...
Cite Document
PGR2021-00003, No. 2001 Exhibit - Price et al, ¿¿¿Role of Supplementary Material in Biomedical Journal Articles Surveys of Authors, Reviewers and Readers,¿¿¿ BMJ Open 2018 20188e021753 doi101136bmjope
+ More Snippets
Document
PGR2021-00003, No. 2002 Exhibit - Pop and Salzberg, ¿¿¿Use and Mis Use of Supplementary Material in Scientific Publications,¿¿¿ BMC Bioinformatics 2015 16237 ¿¿¿Pop Salzberg¿¿¿ (P.T.A.B. Ja...
Cite Document
PGR2021-00003, No. 2002 Exhibit - Pop and Salzberg, ¿¿¿Use and Mis Use of Supplementary Material in Scientific Publications,¿¿¿ BMC Bioinformatics 2015 16237 ¿¿¿Pop Salzberg¿¿¿ (P.T.A.B. Jan. 19, 202
+ More Snippets
Document
PGR2021-00003, No. 2003 Exhibit - Chen et al, US Patent Pub No 20070269375A1 ¿¿¿Chen 375¿¿¿ (P.T.A.B. Jan. 19, 2021)
Cite Document
PGR2021-00003, No. 2003 Exhibit - Chen et al, US Patent Pub No 20070269375A1 ¿¿¿Chen 375¿¿¿ (P.T.A.B. Jan. 19, 2021)
+ More Snippets
Document
PGR2021-00003, No. 2004 Exhibit - Liu et al, ¿¿¿Ascorbic Acid Useful as a Buffer Agent and Radiolytic Stabilizer for Metalloradiopharmaceuticals,¿¿¿ Bioconjugate Chem, 2003, 14, 1052 1056 ¿¿¿Li...
Cite Document
PGR2021-00003, No. 2004 Exhibit - Liu et al, ¿¿¿Ascorbic Acid Useful as a Buffer Agent and Radiolytic Stabilizer for Metalloradiopharmaceuticals,¿¿¿ Bioconjugate Chem, 2003, 14, 1052 1056 ¿¿¿Liu 2003¿
+ More Snippets
Document
PGR2021-00003, No. 2005 Exhibit - Printouts from the New England Journal of Medicine website ¿¿¿NEJM Authors Center¿¿¿App¿¿¿x 1 Publication Process App¿¿¿x 2 What to Expect App¿¿¿x 3 Ne...
Cite Document
PGR2021-00003, No. 2005 Exhibit - Printouts from the New England Journal of Medicine website ¿¿¿NEJM Authors Center¿¿¿App¿¿¿x 1 Publication Process App¿¿¿x 2 What to Expect App¿¿¿x 3 New Manuscr
+ More Snippets
Document
PGR2021-00003, No. 1017-14 Exhibit - de Blois (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1017-14 Exhibit - de Blois (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1031-28 Exhibit - Das 3 (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1031-28 Exhibit - Das 3 (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1029-26 Exhibit - Chen (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1029-26 Exhibit - Chen (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1023-20 Exhibit - Liu (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1023-20 Exhibit - Liu (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1020-17 Exhibit - Breeman 2003 (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1020-17 Exhibit - Breeman 2003 (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1030-27 Exhibit - FDA Guidance (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1030-27 Exhibit - FDA Guidance (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1013-10 Exhibit - 536 Patent (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1013-10 Exhibit - 536 Patent (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1005-4 Exhibit - Maus Declaration (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1005-4 Exhibit - Maus Declaration (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1008-5 Exhibit - Hsieh Yee Declaration (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1008-5 Exhibit - Hsieh Yee Declaration (P.T.A.B. Oct. 2, 2020)
+ More Snippets